Page last updated: 2024-11-02

pifithrin and Idiopathic Parkinson Disease

pifithrin has been researched along with Idiopathic Parkinson Disease in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karunakaran, S1
Saeed, U1
Mishra, M1
Valli, RK1
Joshi, SD1
Meka, DP1
Seth, P1
Ravindranath, V1
Chou, J1
Greig, NH1
Reiner, D1
Hoffer, BJ1
Wang, Y1

Other Studies

2 other studies available for pifithrin and Idiopathic Parkinson Disease

ArticleYear
Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Nov-19, Volume: 28, Issue:47

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Benzothiazoles; Brain;

2008
Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-α.
    Cell transplantation, 2011, Volume: 20, Issue:9

    Topics: Animals; Behavior, Animal; Benzothiazoles; Brain Tissue Transplantation; Cell Count; Cell Survival;

2011